Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to
Influence of culture medium characteristics on the ability to oxidize low-density lipoproteins
β Scribed by M.A. Pech; I. Myara; N. Moatti; A. Caprani
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 751 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1567-5394
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We conducted this study to investigate whether antioxidized low-density lipoprotein (a-oxLDL) is an antibody to cryptic and/or neo-antigen on p,-glycoprotein I (GPI), which is introduced by binding to anionic phospholipid, similar to that of GPI-dependent anticardiolipin antibody (aCL) employing a-o
An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors.
The effect of amphotericin B on the oxidation and degradation of low- and high-density lipoproteins was investigated by UV-vis spectroscopy, electron microscopy, electrophoresis, and size-exclusion chromatography. Two formulations of the drug were used: the commercial Fungizone and a new, less toxic
## Abstract Two isoflavones __in vivo__ metabolites, genisteinβ7β__O__βΞ²βDβglucuronic acid (G7G) and daidzeinβ7β__O__βΞ²βDβglucuronic acid (D7G) were synthesised chemically. The ability of these metabolites to scavenge an organic radical was measured by the trolox equivalent antioxidant capacity (TE